Mizuho Markets Americas LLC Has $7.15 Million Position in The Clorox Company (NYSE:CLX)

Mizuho Markets Americas LLC raised its stake in The Clorox Company (NYSE:CLX) by 3.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 43,870 shares of the company’s stock after buying an additional 1,315 shares during the quarter. Mizuho Markets Americas LLC’s holdings in Clorox were worth $7,147,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in CLX. Archer Investment Corp boosted its stake in shares of Clorox by 4,023.4% during the 3rd quarter. Archer Investment Corp now owns 2,639 shares of the company’s stock valued at $430,000 after buying an additional 2,575 shares during the period. Empirical Finance LLC raised its holdings in shares of Clorox by 2.2% during the third quarter. Empirical Finance LLC now owns 4,274 shares of the company’s stock worth $696,000 after acquiring an additional 93 shares in the last quarter. CIBC Asset Management Inc boosted its position in Clorox by 6.7% during the third quarter. CIBC Asset Management Inc now owns 21,144 shares of the company’s stock valued at $3,445,000 after purchasing an additional 1,332 shares during the last quarter. OneDigital Investment Advisors LLC purchased a new position in Clorox in the third quarter valued at about $207,000. Finally, Huntington National Bank grew its stake in Clorox by 4.2% in the third quarter. Huntington National Bank now owns 13,786 shares of the company’s stock valued at $2,246,000 after purchasing an additional 559 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

NYSE:CLX opened at $167.69 on Friday. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The stock has a market cap of $20.76 billion, a P/E ratio of 58.43, a PEG ratio of 3.06 and a beta of 0.41. The company has a fifty day moving average price of $162.45 and a 200 day moving average price of $147.47. The Clorox Company has a one year low of $127.60 and a one year high of $169.09.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the business earned $0.49 earnings per share. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. Analysts anticipate that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.91%. The ex-dividend date was Wednesday, October 23rd. Clorox’s payout ratio is presently 170.04%.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.57% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CLX has been the subject of several research reports. Deutsche Bank Aktiengesellschaft lifted their price target on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and increased their price target for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Evercore ISI cut their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Finally, TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their price target for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $155.00.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.